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Endothelin stimulates PDGF secretion in cultured human mesangial
cells. Endothelin, a l7-DKa peptide originally described as a potent
vasoconstrictor, also stimulates the release of important regulators of
glomerular hemodynamics such as atrial natriuretic factor and renin. In
the present study we investigated the role of endothelin in the release of
another potent vasoconstrictor and mitogen of human mesangial cells,
the platelet-derived growth factor. Endothelin stimulated PDGF release
at 12 hours and the effect was sustained for 36 hours. This effect was
associated with the enhanced induction of mRNAs encoding PDGF A-
and B-chain. Endothelin also induced mitogenesis in human mesangial
cells which was accompanied by activation of phospholipase C with
increased inositol phosphate turnover. These data suggest a mechanism
by which endothelin may regulate mesangial cell function in disease
states.
Endothelin, a novel vasoconstrictor, has recently been pun
fled from medium conditioned by porcine aortic endothelial
cells [11. It is a potent vasoconstnictor of isoJated blood vessels
in vitro and of various vascular hed in viva [2—51. The most
pronounced vasoconstrictor effects of endothelin so far re-
ported are observed in the kidney [6]. Combined in vivo and in
vitro studies in rats suggest that endothelin reduces glomertilar
filtration rate via its contractile effect on mesangial cells [7].
Evidence is rapidly accumulating to show that signals trans-
duced in response to endothelin in both smooth muscle and rat
mesangial cells include activation of phospholipases C and A,,
changes in cytosolic calcium, intracellular alkaliniyation and
protooncogene activation {7—13]. We have recently demon-
strated that human glomerular mesangial cells in culture ex-
press mRNAs that encode for both the A- and B-chain of PDGF
and release PDGF [14]. Agents that activate phospholipase C
and protein kinase C, including PDGF itself, thrombin and
phorbol esters, enhance PDGF gene expression and release of
PDGF from mesangial cells [15—18]. Mesangial cells also ex
press receptors for PDGF that recogni7e at least two PDGF
isoforms PDGF AB and PDGF RB [14. 15]. These observations
suggest that PDGF genes and/or their released product(s) may
be involved in the mitogenic response to a variety of growth
factors. We studied the effect of endothelin on PDGF secretion
and expression of PDGF mRNAs. In addition, we determined if
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endothelin activates phospholipase C, and if it is mitogenic to
human mesangial cells as has recently been reported for rat
mesangial cells.
Methods
Meson gial ce/I cultures
Human mesangial cells were cultured from isolated glomeruli
of normal human kidney tissue obtained from nephrectomy
samples. Detailed characterization of the cells have been re-
ported previously [14]. Cells were used between passages five
and ten.
Measurement of released PDGF activity
Human mesangial cells grown to confluence in 100 mm Petri
dishes, were washed twice with serum free medium, and
exposed to endothelin for the time periods indicated. Condi-
tioned media was then collected, centrifuged at 2000 rpm for 10
minutes to remove cell debris, and stored at 00 until assayed.
For PDGF assay, human foreskin flhrohlasts were placed on ice
and washed with DVF-12 medium containing 25 msi HEPES
and 2 mg/mI bovine serum albumin (BSA, binding medium).
Binding medium alone or binding medium containing various
aliquots of conditioned medium or standard concentrations of
purified PDGF were added to duplicate wells. Fibroblasts were
incubated for one hour at room temperature with constant,
gentle rotary agitation. The media was aspirated, the cells were
washed once with binding medium and 1251-PDGF in binding
medium was then placed on the cells for one hour at room
temperature. Cells were then washed twice with ice-cold PBS
containing 1 mrvi CaCI2 and 2 mg/mI BSA and solubilized with
1% Triton X-100 containing 1 mg/mI BSA. The cell-bound
radioactivity was measured. PDGF in the conditioned medium
was quantitated from standard curves of competitor activity of
punied PDGF as previously described [16].
RNA purification and Northern blotting
Cultured human mesangial cells were washed in phosphate
buffered saline and lysed in giianidinium isothiocyanate and
RNA prepared after centrifugation on cesium chloride gradi-
ents. Samples containing total RNA were fractionated on 1%
agaroseformaldehyde gels and transferred to GeneScreen
(NEN) overnight. Prehybridization and hybridization were per-
formed overnight at 42C in a hybridization buffer containing
50% formamide, 0.8 M NaCI, 0.02 M 1,4 piperazindiethane-
sulfonic acid pH 6.5, 20 misi EDTA, 100 tg/ml of denatured
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salmon sperm DNA and 0.5% SDS. The probe used for the
hybridization was an A-chain cDNA provided by C. Betsholtz
and C.H. Heldin [19]. This cDNA was subcloned into M13 mp8
and a clone containing the sense strand was used as a template
for cDNA synthesis with the Kienow fragment of DNA poly-
merase I and the M13 universal sequencing primer as described
[15]. Afterhybridization, blots were washed successively in 2 x
SSC, 0.5% SDS at 23°C, the same buffer at 65°C and 0.1 x SSC
0.5% SDS at 23°C.
Solution hybridization assay
The levels of c-sis mRNA were determined using a ribonu-
clease protection (solution hybridization) assay. The probe
used was a genomic fragment of the c-sis gene subcloned into
the sma I site of pT7-2 (US Biochemical). The RNA probe was
synthesized from the DNA template using T7 polymerase. For
hybridization, 50 g aliquots of total RNA prepared from
mesangial cells were distributed in Eppendorf tubes, and dried
in a speed vac. Hybridization was carried out by adding the
labeled RNA probe (1 x 106 cpm) to the RNA samples in the
presence of 80% formamide, 10 m Pipes pH 6.4, 400 mrvi NaCl
and 1 mr,s EDTA, followed by overnight incubation at 50°C in a
water bath. After hybridization, samples were digested with
RNase A (50 ig/ml) and RNase T1 (2 pgIml) followed by the
addition of proteinase K to inactivate the remaining RNase.
After extraction and the addition of t-RNA, samples were
precipitated and redissolved in loading buffer containing 90%
formamide, and separated on 6% polyacrylamide/urea gels.
Autoradiograms of the gels were exposed after 48 hours using
enhancing screens. The sis bands were identified by their
position which corresponds to the sixth and seventh exons of
the undigested probe.
[3H]-Thymidine incorporation
DNA synthesis was measured as the amount of [3H]-thymi-
dine incorporated into trichioroacetic acid insoluble material
[14]. Cells were plated in 24 well dishes in Waymouth's medium
containing 17% serum until they became confluent. Cells were
then made quiescent by incubation in Waymouth's medium
containing 1% Zeta serum but free of insulin or FCS for three
days. Endothelin was added and after 24 hours the cells were
pulsed with [3H]-thymidine for four hours at 37°C. At the end of
the four hour pulse period, medium was removed and ice-cold
5% trichloroacetic acid was added for 15 minutes and dishes
were kept on ice. After two more washes with the acid, cells
were solubilized by adding 0.25 N NaOH and 0.1% SDS. One
half ml of this solubilized cell solution was then neutralized and
counted in a scintillation counter.
Cell pro! jferation assay
Subconfluent human mesangial cells were plated in Way-
mouth's medium with 17% FCS. After 24 hours, the cells were
washed and placed in SFIF in the presence or absence of
endothelin. Cell counts were performed on quaduplicate wells
every two or three days by trypsinizing the cells and counting in
Coulter counter.
Analysis of inositol phosphates
Confluent mesangial cells were washed and placed in serum-
free media three days prior to the assay. The media was
switched to inositol-free RPMI 1640 media (Gibco, Grand
Island, New York, USA) containing 3 pCi/mI PH]-myoinositol
(New England Nuclear, Boston, Massachusetts, USA) 36 hours
before the assay. Medium was removed and cells were washed
twice with Hepes buffer, containing 1.3 mri Ca to remove
unincorporated label. In experiments in which the length of the
incubation was five minutes or greater, 7.5 m lithium chloride
was included in the buffer, and the second wash was left on the
cells for 10 minutes. Test substances, diluted in Hepes buffer,
were added to duplicate or triplicate wells and incubated for the
times indicated at 37°C. The incubation was terminated by
aspirating the buffer and adding 5% perchloric acid to each well.
The dishes were refrigerated for two hours, to allow complete
extraction of the water soluble inositols. The solution was then
removed and 10 N KOH was added to precipitate the perchlo-
rate. The samples were centrifuged, the supernatant removed
and neutralized with 5 mM sodium tetraborate (pH 8.8). Each
sample was separated on 1 ml AG 1-X 8 anion-exchange
columns (Bio-Rad) by loading the samples, washing with 20 ml
distilled H20, and then eluting with 8 to 10 ml of increasing
concentration of NH4 formate in 0.1 M formic acid. Using this
technique, inositol monophosphate elutes with 0.2 M NH4
formate, inositol bis-phosphate with 0.4 M NH4 formate, and
inositol tns-phosphate with 1 M NH4 formate. Two ml of each
collected fraction was mixed with Scintiverse E scintillation
fluid and counted in a beta counter. The acid-insoluble protein
remaining in the tissue culture wells was solubilized with NaOH
and assayed for protein. Results are expressed as cpm [3H]-
inositol/g protein.
Results
Release of PDGFactivity in response to endothelin
Conditioned medium was collected from confluent quiescent
mesangial cells treated with endothelin and analyzed for the
presence of PDGF by a radioreceptor assay. In the absence of
endothelin, mesangial cells constitutively released PDGF activ-
ity. The cumulative PDGF activity in ng PDGF equivalent is
shown in Table I. Cells exposed to 10—8 M endothelin continued
to release more PDGF activity than did untreated cells.
Regulation of the PDGF A-chain and c-sis mRNAs by
endothelin
To determine if the release of PDGF activity is associated
with secretion of newly synthesized rather than preformed
PDGF, expression of the genes for the A-chain and B-(c-sis)
chains of PDGF was assessed in cells treated with endothelin.
Figure 1 shows a representative Northern blot demonstrating
the expression of A-chain mRNA in human mesangial cells
treated with endothelin 10_s M for various time points. Three
A-chain transcripts 2.3, 1.9 and 1.5 kilobases, are detected in
mesangial cell mRNA as previously reported [15]. In the
presence of endothelin there was 1.9-fold increase in the
amount of message by four hours that remained elevated for up
to 24 hours. When the same blot was hybridized to an alpha-
tubulin probe, there were no time dependent alterations in the
expression of this gene, demonstrating that the response in
A-chain mRNA does not simply reflect a generalized nonspe-
cific change in total RNA expression.
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Table 1. Effect of endothelin on PDGF secretion
12 hrs 24 hrs 36 hrs
Control Endoth.Control Endoth. Control Endoth.
Exp 1 0.4 0 0.75 0.20 1.7 0 2.15 0.1 4.0 0.7 6.4 0
Exp 2 — — 0.25 0 0.35 0.03 1.65 0.1 2.05 0.1
Exp 3 0.06 0.02 0.16 0.01 0.07 0.01 0.17 0.02 0.29 0.01 0.43 0.0!
Mean SEM 0.303 0.12 0.45 0.17 0.67 0.5 0.89 0.6 1.98 1.0 2.96 1.7
Confluent mesangial cells in 100 mm Petri dishes were incubated in serum free medium for 3 days. Endothelin at a concentration of l0- M was
added at the end of 3 day incubation. Medium collected was centrifuged, and assayed for PDGF as described in Methods. Values represent
cumulative levels of PDGF that is secreted during times indicated. Values are in ng PDGF/106 cells and are average range of duplicate samples.
Table 2. Effect of endothelin on DNA synthesis
Fig. 1. Northern blot of induction of PDGF-A chain mRNA in mesan-
gial cells in response to endothelin. Cells were made quiescent in
serum-free media for 3days prior to exposure to endothelin (lO_8 M). At
the time points indicated, the cells were harvested and RNA was
isolated. Control (C) represents RNA isolated from cells incubated
without endothelin. Each lane Contains IS g of total RNA. After
hybridization with a single stranded A-chain cDNA, the probe was
removed by boiling and the blot was rehybridized to a single stranded
alpha-tubulin eDNA probe. Blots were exposed to Kodak XAR film
with intensifying screens overnight at —70°C (representative of three
experiments).
Fig. 2. Induction of PDGF-B chain mRNA (c-sis) in mesangial cells in
response to endothelin. Confluent cells were placed in serum-free media
for 3 days prior to exposure to endothelin or PMA. At the time points
indicated the cells were harvested and RNA was isolated. A total of 50
zg samples of total RNA from mesangial cells were hybridized with a
uniformly labeled c-sis RNA probe. Following digestion with RNAases
A and T1, protected fragments were electrophoresed on a denaturing
polyacrylamide gel and detected by autoradiography (representative of
three experiments).
Because of the low abundance of the c-sis mRNA expression
in mesangial cells, we used a solution hybridization technique
to determine if endothelin also regulates the induction of PDGF
B-chain mRNA. As shown in Figure 2, endothelin increased the
level of B-chain mRNA over that in control cultures, with
similar time course kinetics to those for A-chain inductjon. The
[3H]-Thymidine incorporation cprn
Serum free 1% Z Serum
Control 2652 156 2731 331
EN 10-12 2450 179 3037 446
EN 10' 2596 192 3159 460
EN 10- '° 3206 367 4308 789
EN l0 3406 364 4968 752°
EN 10_s 3469 209° 5392 925°
Cells were plated in 24 well dishes at a density of 2 x l04/well and
maintained in Waymouth medium with FCS until confluent. Cells were
then made quiescent and incubated with various concentrations of
endothelin for 24 hours followed by a 4 hour pulse with [3H]-thymidine.
Cells were then harvested as described in Methods. Data represent
average range of three experiments, each assayed in triplicate wells.a P < 0.05.
effect on both A-chain and c-sis mRNAs is not transient, but
progressive and prolonged, unlike the transient induction we
have observed in response to other peptide mitogens [15]. This
prolonged effect most likely reflects a cumulative effect of
endothelin by irreversible binding to its putative receptor site
[20—23]. Also shown in Figure 2 is the stimulatory effect of
phorbol myristate acetate (PMA) on PDGF B-chain mRNA.
PMA markedly increase the steady state levels of PDGF
B-chain mRNA. The modest accumulation of PDGF A- and
B-chain mRNAs is associated with an increase in the PDGF
activity released by the cells in response to endothelin as shown
in Table I.
Effect of endothelin on DNA synthesis
Endothelin stimulates DNA synthesis in mesangial cells as
assessed by [3H]-thymidine incorporation into DNA in a dose
dependent manner, as shown in Table 2. Maximal stimulation of
DNA synthesis was observed at a dose of l0_8 M and the
half-maximal stimulation at 7 x 10_Il M. This is compatible
with the potency of the peptide for stimulating smooth muscle
contraction. The addition of endothelin in the presence of 1%
Zeta Serum caused a further dose dependent increase in [3H1-
TdR incorporation. The mitogenic effect of endothelin was
further demonstrated by cell counting, as shown in Table 3.
Effect of endothelin on inositol phosphates
We next investigated if DNA synthesis in response to endo-
thelin is associated with activation of phospholipase C. As
shown in Figure 3A, endothelin increased turnover of total
inositol phosphates measured at 30 minutes. Inositol phosphate
turnover was significantly elevated in response to lO_8 Mand
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Table 3. Effect of endothelin on mesangial celi growth
Days
Cell number x i04
Serum free
Endothelin
10 M
0
3
5
3.2±0.1
12.5 0.8
20.8 0.1
3.2±0.1
15.4 o.r
27.0 0.3k
Mesangial cells were plated in 24 well dishes in Waymouth medium
containing FCS. Following cell attachment overnight, the subconfluent
cells were washed with serum free medium and placed in SFIF medium
with or without 10 Mendothelin. At indicated time points, cells were
trypsinized and counted in a Coulter counter. Counts are mean SEM
from quadruplicate wells.
* Significant difference from control wells, P < 0.05
i0 M endothelin. As shown in Figure 3B endothelin (10-8 M)
induces an increase in all three inositol phosphates. Inositol bis-
and tris-phosphate increase promptly, peak within 60 seconds
and then reach new steady state levels at two minutes. In
contrast to these two inositol phosphates, inositol monophos-
phate continues to increase at two minutes. These results
indicate that endothelin activates phospholipase C which cata-
lyzes the breakdown of polyphosphinositides.
Discussion
We have demonstrated that endothelin stimulates PDGF
release and induces the steady state levels of the PDGF A-chain
and B-chain (c-sis) mRNAs in human mesangial cells. In
addition, endothelin activates phospholipase C and stimulates
DNA synthesis and proliferation of human mesangial cells. Our
finding that endothelin stimulates release of PDGF by smooth
muscle-like mesangial cells expands the potential role of endo-
thelin in modulating the biology of the microvascular wall. If
glomerular endothelial cells release endothelin analogous to
other endothelial cells [20, 21], endothelin should be readily
accessible to mesangial cells in both physiologic and pathophys-
iologic states. In an analogous matter, it is likely that endothelin
released by endothelial cells affect adjacent smooth muscle cells
in other vascular beds [22]. Released PDGF in response to
endothelin may regulate growth of mesangial and perhaps
smooth muscle cells, since both cell types express PDGF
receptors. The observation that the enhanced PDGF activity in
the medium in response to endothelin is associated with in-
creased expression of PDGF mRNAs suggests that at least a
portion of this activity results from de novo protein synthesis. It
should be emphasized that the amount of PDGF activity mea-
sured in the conditioned medium may underestimate the actual
amounts synthesized by the cells, since our radioreceptor assay
is not optimal for measuring the various PDGF isoforms. In
addition, a portion of PDGF may bind to PDGF receptors on
the cells without being secreted. It remains to be determined
what form of PDGF is released by human mesangial cells after
stimulation by endothelin. Whether the secreted protein is a
homodimer (A-A or B-B) or heterodimer (AB) or a combination
of three isoforms needs to be explored. However, the levels of
PDGF B-chain mRNA expression either con stitutive or induced
are very low, as they cannot be detected with Northern blot
analysis. While PDGF AA is likely to be the major isoform
secreted by mesangial cells, other factors besides the relative
Fig. 3. Endothelin-inducedstimulation of inositol phosphates. Inositol
phosphates were extracted and separated on AG l-X8 column as
described in Methods. A. Effect of increasing concentrations of endo-
thelin on total inositol phosphate levels at 30 minutes. Each bar
represents the average range of 2 experiments, each assayed in
duplicate wells. Endothelin at a concentration of 108 M and l0- M
significantly stimulated total inositol phosphates, *D < 0.001. B. Time
course for the increase in inositol monophosphate (1P1) inositol bisphos-
phate (lP2), and inositol trisphosphate (1P3) in response to 10-8 M
endothelin, each point is the mean from 4 dishes assayed in duplicate.
The SE at all time points is 20% or less of the mean.
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amounts of A or B chain mRNA may influence PDGF dimer
assembly and secretion in a cell specific manner.
Of major interest is our finding that the time course of
induction of PDGF A-chain and c-sis mRNAs in response to
endothelin differs from that in response to other peptide growth
factors. Endothelin elicits a sustained increase in the expression
of both mRNAs, unlike most other peptide growth factors
which stimulate the transient expression of PDGF mRNAs with
a peak effect after four hours. The mechanism that dissociates
this vasoconstrictor from other peptide mitogens is not known,
although one possibility is that endothelin appears to bind
irreversibly to its receptors and elicits a sustained effect, as
demonstrated by Yanigasawa et al and Badr et al [1, 23]. Since
endothelin stimulates phospholipase C, as evidenced by the
increased turnover of phosphoinositides and release of inositol
trisphosphate, it is possible that diacylglycerol-induced activa-
tion of protein kinase C is involved in mediating the release of
PDGF and the increased expression of PDGF mRNAs. This
interpretation is supported by our finding that the protein kinase
C activator phorbol ester, phorbol myristate acetate (PMA) also
increases mesangial cell steady-state PDGF mRNA levels [18].
It has been shown that endothelin stimulates DNA synthesis in
variety of cell lines of mesenchymal origin such as vascular
smooth muscle cells, Swiss 3T3 fibroblasts and rat mesangial
cells [8, 9, 12]. We have recently shown that induction of PDGF
mRNAs in mesangial cells in response to several peptide
growth factors is associated with DNA synthesis [15]. Unlike
recent observations made in rat mesangial cells demonstrating
that endothelin is a comitogen and requires either a cofactor
present in serum, or insulin to express mitogenic activity [12],
endothelin appears to act as a complete mitogen in human
mesangial cells, since DNA synthesis occurred when the cells
were exposed to endothelin alone. However, we cannot ex-
clude that endothelin acts in concert with other growth factors
released by the cells, including PDGF itself, to stimulate DNA
synthesis. Of note is that the mitogenic effect of endothelin was
potentiated in the presence of low concentrations of Zeta
serum. This finding is consistent with the study of Simenson et
al [12] in rat mesangial cells and Takawa et al [9] in smooth
muscle cells, demonstrating that the mitogenic effect of endo-
thelin is potentiated in the presence of serum or PDGF.
Vasoconstrictors have recently been reported to initiate
several cellular processes that are activated by classic mito-
gens, such as phospholipase C cleavage or phosphoinositides,
mobilization of intracellular calcium and Na/H4 exchange [24,
25]. More recently, protooncogene activation have been recog-
nized as an early cellular response to vasoconstrictors [26].
Induction of c-fos and c-myc in response to angiotensin II (Ang
II) have been reported [25, 26]. Clear evidence for a definite
relationship between these signals and DNA synthesis in
mesangial cells or other cell types is still lacking. A role for
phospholipase C in mediating the mitogenic effect of certain
growth factors is suggested by the observation that microinjec-
tion of an antibody that neutralizes phosphatidylinositol 4,5-
bisphosphate (PIP2) inhibits DNA synthesis [27]. However
additional pathways involving novel inositol lipids have re-
cently been proposed [28]. More recently, the role of phospho-
lipase C gamma in DNA synthesis have been questioned [29].
Of interest also is the recent description of constriction as an
additional biologic activity for certain peptide growth factors
such as PDGF and EGF [30, 31]. The association of activation
of many of these signals with endothelin suggest their involve-
ment in mediating some of its biologic effects. It is also likely
that released PDGF and increased expression of PDGF mRNA
may mediate or modulate the mitogenic effect of endothelin in
human mesangial cells in a positive fashion.
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